Cargando…
First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301)
Pharmacologic termination of paroxysmal supraventricular tachycardia (PSVT) often requires medically supervised intervention. Intranasal etripamil, is an investigational fast-acting, nondihydropyridine, L-type calcium channel blocker, designed for unsupervised self-administration to terminate atriov...
Autores principales: | Stambler, Bruce S., Plat, Francis, Sager, Philip T., Shardonofsky, Silvia, Wight, Douglas, Potvin, Diane, Pandey, A. Shekhar, Ip, James E., Coutu, Benoit, Mondésert, Blandine, Sterns, Laurence D., Bennett, Matthew, Anderson, Jeffrey L., Damle, Roger, Haberman, Ronald, Camm, A. John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760458/ https://www.ncbi.nlm.nih.gov/pubmed/36441560 http://dx.doi.org/10.1161/CIRCEP.122.010915 |
Ejemplares similares
-
Etripamil: Self-management of supraventricular tachycardia is not far away?
por: Faisaluddin, Mohammed, et al.
Publicado: (2019) -
The Efficacy and Safety of Etripamil Nasal Spray for Acute Paroxysmal Supraventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Abuelazm, Mohamed, et al.
Publicado: (2023) -
High-density mapping of the slow pathway in a patient with atrioventricular nodal reentry given intranasal Etripamil during the NODE-1 study
por: Choe, William C., et al.
Publicado: (2017) -
Paroxysmal Supraventricular Tachycardia
por: Arnold, Casey, et al.
Publicado: (2019) -
Malignant Paroxysmal Supraventricular Tachycardia
por: Anguera, I, et al.
Publicado: (2010)